The key importance of soy isoflavone bioavailability to understanding health benefits.
Research over the past two decades has provided significant epidemiological and other evidence for the health benefits of the consumption of soy-based foods. A large number of dietary intervention studies have examined the effects of soy isoflavones on risk factors for cardiovascular disease and hormone-dependent cancers. However, these report large variability in outcome measures, very limited reproducibility between studies, and in some cases, controversy between the results of clinical trials using dietary soy or soy protein and isoflavone supplementation. This highlights a major gap in our understanding of soy isoflavone uptake, metabolism, distribution, and overall bioavailability. There are many potential factors that may influence bioavailability and a better knowledge is necessary to rationalize the inconsistencies in the intervention and clinical studies. This review focuses attention on our current state of knowledge in this area and highlights the importance of metabolism of the parent soy isoflavones and the critical role of gut microbiota on the bioavailability of these compounds and their metabolites.
Smart Food Centre, University of Wollongong, NSW, Australia.
Theresa
T
Larkin
William E
WE
Price
Lee
L
Astheimer
D001682:Biological Availability; D006801:Humans; D007529:Isoflavones / Q000737:chemistry / Q000493:pharmacokinetics*; D015394:Molecular Structure; D045730:Soy Foods / Q000032:analysis; D013025:Glycine max / Q000737:chemistry*
D007529:Isoflavones